MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02
On June 11, 2019, the board of directors (the “Board”) of Medovex Corp. (the “Company”) appointed Briley Cienkosz, Ann Miller and Gary Mancini as executive officers of the Company. Briley Cienkosz was appointed Chief Marketing Officer at a base salary of $265,000. Ann Miller was appointed Chief Operating Officer at a base salary of $200,000. Gary Mancini was appointed Chief Relationship Officer at a base salary of $150,000 plus potential bonus, such bonus being subject to Mr. Mancini’s team achieving certain to be determined financial metrics.
Set forth below is a biography of each of the new officers.
Brieley Cienkosz, 35, as Chief Marketing Officer, is responsible for brand strategy, corporate communications and integrated marketing efforts at the Company. Prior to joining the Company in January 2019, Ms. Cienkosz was the Chief Marketing Officer at Regenerative Medicine Solutions from January 2018. She was the Chief Marketing Officer at Laser Spine Institute from June 2014 to January 2018 where she was an integral part of implementing their first DRTV (direct response television) campaign, while also assisting in the launch of four ambulatory surgery centers. Ms. Cienkosz earned a B.S. in marketing from Southern Illinois University and an MBA from the University of Wisconsin.
Ann Miller, 39, as Chief Operating Officer, is responsible for leading operations through research evaluation and implementation on key business strategies to improve performance and organizational development as it relates to patient satisfaction, quality core standards and revenue generation. Prior to joining the Company, Ms. Miller was an Executive Vice President at Regenerative Medicine Solutions from June 2014 to January 2019 when she joined the Company. Ms. Miller has a bachelor’s degree in Anthropology from Tulane University.
Gary Mancini, 38, as Chief Relationship Officer, ensures that the Company’s patients get the best care possible. Prior to joining the Company in January 2019, Mr. Mancini was the Vice President of Patient Services for Regenerative Medicine Solutions from March 2018 to January 2019 and held the same title at Laser Spine Institute from June 2014 to March 2018. At Laser Spine Institute, Mr. Mancini coordinated over 60,000 patient surgeries. Mr. Mancini earned a bachelor’s degree in finance and marketing from Florida State University.
